Clinical Trial Update: Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating duloxetine for depression in patients with traumatic brain injury; the trial was terminated and results were posted in 2014…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Traumatic Brain Injury

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Rehabilitation Hospital of Indiana | Conditions: Traumatic Brain Injury, Depression | Phase 2 | Status: TERMINATED | Results posted: 2014-12-17